Sonoma Pharmaceuticals
SNOA
#10906
Rank
โ‚น0.65 B
Marketcap
โ‚น137.09
Share price
15.20%
Change (1 day)
-48.89%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -โ‚น0.22 Billion

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are โ‚น19.52 Million. In 2025 the company made an earning of -โ‚น0.27 Billion, an increase over its 2024 earnings that were of -โ‚น0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น0.22 Billion-17.41%
2025 -โ‚น0.27 Billion-38.02%
2024 -โ‚น0.43 Billion0.54%
2023 -โ‚น0.43 Billion-31.5%
2022 -โ‚น0.62 Billion16.86%
2021 -โ‚น0.53 Billion194.32%
2020 -โ‚น0.18 Billion-58.76%
2019 -โ‚น0.44 Billion-65.66%
2018 -โ‚น1.27 Billion4.84%
2017 -โ‚น1.21 Billion-2.17%
2016 -โ‚น1.24 Billion32.12%
2015 -โ‚น0.94 Billion-307.74%
2014 โ‚น0.44 B-197.5%
2013 -โ‚น0.47 Billion
2010 -โ‚น0.73 Billion-14.02%
2009 -โ‚น0.84 Billion-57.28%
2008 -โ‚น1.97 Billion-8.03%
2007 -โ‚น2.14 Billion3.85%
2006 -โ‚น2.06 Billion39.31%
2005 -โ‚น1.48 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น21.8 Billion 9,202.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.73 Billion 637.75%๐Ÿ‡บ๐Ÿ‡ธ USA